Pharmaceuticals, Biotechnology and Life Sciences
Data presented at The Society for the Immunotherapy of Cancer 35th Anniversary Annual Meeting Eight of nine patients treated on…
Shape strategic responses through the phases of industry recovery Anchor Packaging Inc., Cascades Inc., and CKF Inc. will emerge as major foam…
AbCellera’s partner, Eli Lilly and Company, will supply the U.S. government with 300,000 doses of bamlanivimab for allocation to high-risk…
SAN DIEGO–(BUSINESS WIRE)–La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that…
FLORHAM PARK, N.J.–(BUSINESS WIRE)–Please replace the photo with the accompanying corrected photo. The release reads: Xiromed LLC Launches Gemmily™, First-to-Market…
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK— Merck Announces KEYNOTE-598 Trial Evaluating KEYTRUDA® (pembrolizumab) in Combination With Ipilimumab Versus KEYTRUDA Monotherapy in Certain…
– MARIO-275 IDMC Determined that Risk/Benefit for Patients Warrants Resumption of Enrollment; Infinity to Determine Next Steps by Year End…
Total Revenue of $51.4 Million was Flat Versus Q3 2019 and Up 2.0% Compared to Q2 2020 – Excluding Bulk…
Announced Positive Updated Data from Ongoing Investigator-Initiated Phase 1/2 FRAME Study Evaluating VS-6766 and Defactinib Combination in Patients with Low-Grade…
TORRANCE, Calif.–(BUSINESS WIRE)–Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced third quarter 2020 financial results and…